Completed PHASE2 INTERVENTIONAL 1-arm
NCT00947453
Sputum Matrix Metalloproteinases (MMP) mRNA and Montelukast
The Effect of Montelukast Therapy on mRNA Profile of Matrix Metalloproteinases and Their Inhibitors in the Sputum of Patients With Asthma
Sponsor: Clinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK)
Conditions
Asthma
Interventions
montelukast
Updated 1 time since 2024 Last updated: Aug 22, 2012 Started: Jul 31, 2009 Primary completion: Dec 31, 2011 Completion: Dec 31, 2011
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT00947453, this PHASE2 trial focuses on Asthma and remains completed. Sponsored by Clinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK), it has been updated 1 time since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
1 version recorded Completed — PHASE2
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Clinical Research and Trials Unit (Norfolk & Norwich University Hospital, UK)
- University of East Anglia
Data source: University of East Anglia
For direct contact, visit the study record on ClinicalTrials.gov .